Status and phase
Conditions
Treatments
About
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate ICP-488.Efficacy, safety, PK, and PD characteristics in Chinese adults with moderate to severe plaque psoriasis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
129 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Alexia Lu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal